Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - omeprazolum - capsule - omeprazolum 20 mg, sacchari sphaerae cum saccharum max. 39.88 mg et maydis amylum, hypromellosum, natrii laurilsulfas, magnesii oxidum ponderosum, povidonum k 25, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, kapselhülle: gelatina, aqua purificata, e 171, pro capsula corresp. natrium 0.06 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - omeprazolum - compresse rivestite con film - omeprazolum 10 mg ut omeprazolum magnesicum, sacchari sphaerae corresp. saccharum ca. 4.9 mg et maydis amylum et glucosum liquidum ca. 0.27 mg, copovidonum, povidonum, talcum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, glyceroli monostearas 40-55, propylenglycolum, acidum stearicum, polysorbatum 80, simeticonum, cellulosum microcristallinum, macrogolum 6000, crospovidonum, silica colloidalis anhydrica, magnesii stearas, e 171, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), e 172 (rubrum) pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - omeprazolum - compresse rivestite con film - omeprazolum 20 mg ut omeprazolum magnesicum, sacchari sphaerae corresp. saccharum ca. 9.8 mg et maydis amylum et glucosum liquidum ca. 0.54 mg, copovidonum, povidonum, talcum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, glyceroli monostearas 40-55, propylenglycolum, acidum stearicum, polysorbatum 80, simeticonum, cellulosum microcristallinum, macrogolum 6000, crospovidonum, silica colloidalis anhydrica, magnesii stearas, e 171, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, e 172 (rubrum) pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - omeprazolum - compresse rivestite con film - omeprazolum 40 mg ut omeprazolum magnesicum, sacchari sphaerae corresp. saccharum ca.19.6 mg et maydis amylum et glucosum liquidum ca. 1.08 mg, copovidonum, povidonum, talcum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, glyceroli monostearas 40-55, propylenglycolum, acidum stearicum, polysorbatum 80, simeticonum, cellulosum microcristallinum, macrogolum 6000, crospovidonum, silica colloidalis anhydrica, magnesii stearas, e 171, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), e 172 (rubrum) pro compresso obducto. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 10 mg, sacchari sphaerae corresp. saccharum 40.01 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 0.45 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 20 mg, sacchari sphaerae corresp. saccharum 80.02 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 1.51 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 40 mg, sacchari sphaerae corresp. saccharum 160.05 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 3.03 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - omeprazolum - capsule gastroresistenti - omeprazolum 10 mg, excipiens pro capsula. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - omeprazolum - capsule gastroresistenti - omeprazolum 20 mg, excipiens pro capsula. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - omeprazolum - capsule gastroresistenti - omeprazolum 40 mg, excipiens pro capsula. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika